Cardioprotection before revascularization in ischemic myocardial injury and the potential role of hemoglobin-based oxygen carriers

American Heart Journal

Volumn 149, Issue 4, 2005, Pages 573-579

  Burkhoff, Daniel ^a,c   Lefer, David J ^b  

^a College of Physicians and Surgeons ^*  (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN BASED OXYGEN CARRIER; HEMOGLOBIN DERIVATIVE; HEMOSPAN; PLACEBO; POLYMERIZED HEMOGLOBIN; UNCLASSIFIED DRUG;

CLINICAL TRIAL; CORONARY ARTERY DISEASE; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HUMAN; NONHUMAN; OXYGEN TRANSPORT; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; TISSUE OXYGENATION; VISCOSITY;

EID: 17044425620     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.06.028     Document Type: Review

References (52)

1. K. Detre, M. Murphy, and H. Hultgren Effect of coronary bypass surgery on longevity in high and low risk patients: report from the V A Cooperative Coronary Surgery Study Lancet 2 1977 1243 1245
2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Randomized trials of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2 Lancet 2 1988 349 360
3. E. Varnauskas Twelve-year follow-up of survival in the randomized European Coronary Surgery Study N. Engl. J. Med. 319 1988 332 337
4. The GUSTO investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N. Engl. J. Med. 329 1993 673 682
5. The GUSTO-IIb angioplasty substudy investigators A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction N. Engl. J. Med. 336 1997 1621 1628
6. H. Suryapranata, A.W.J. van't Hof, and J.C.A. Hoorntje Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction Circulation 97 1998 2502 2505
7. S.E. Sheifer, S.S. Rathore, and B.J. Gersh Time to presentation with acute myocardial infarction in the elderly: associations with race, sex, and socioeconomic characteristics Circulation 102 2000 1651 1656
8. W.J. Rogers, J.G. Canto, and H.V. Barron Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. Investigators in the National Registry of Myocardial Infarction J. Am. Coll. Cardiol. 35 2000 380 381
9. I. Holban Cardioprotection during myocardial revascularization: benefit of a metabolic intervention Heart Metab. 12 2001 24 26
10. L.B. Pearce, and M.S. Gawryl The pharmacology of tissue oxygenation by Biopure's hemoglobin-based oxygen carrier. Hemopure (HBOC-201) Adv. Exp. Med. Biol. 530 2003 261 270
11. M. Kavdia, R.N. Pittman, and A.S. Popel Theoretical analysis of the effects of blood substitute affinity and cooperativity on organ oxygen transport J. Appl. Physiol. 93 2002 2122 2128
12. S.E. Hill Oxygen therapeutics-current concepts Can. J. Anaesth. 48 4 Suppl. 2001 S32 S40
13. CDC Mortality from coronary heart disease and acute myocardial infarction-United States, 1998 MMWR Morb. Mortal. Wkly. Rep. 50 2001 90 93
14. American Heart Association 2003 Heart and Stroke Statistics-2003 Update 2002 American Heart Association Dallas (Tex) 1 43
15. D.C. Goff Jr., G. Howard, and C.H. Wang Trends in severity of hospitalized myocardial infarction: the atherosclerosis risk in communities (ARIC) study, 1987-1994 Am. Heart J. 139 2000 767 770
16. M.G. Hunink, L. Goldman, and A.N. Tosteson The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment JAMA 277 1997 535 542
17. R. Cooper, J. Cutler, and P. Desvigne-Nickens Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States. Findings of the National Conference on Cardiovascular Disease Prevention Circulation 102 2000 3137 3147
18. J.P. Hellermann, S.J. Jacobsen, and G.S. Reeder Heart failure after myocardial infarction: prevalence of preserved left ventricular systolic function in the community Am. Heart J. 154 2003 742 748
19. CDC Changes in mortality from heart failure-United States, 1980-1995 MMWR Morb. Mortal. Wkly. Rep. 47 1998 633 637
20. S. Coccolini, C. Fresco, and P.M. Fioretti Early prehospital thrombolysis in acute myocardial infarct: a moral obligation? Ital. Heart J. 4 2 Suppl. 2003 102 111
21. K.M. Detre, and R. Holubkov Coronary revascularization on balance: Robert L. Frye lecture Mayo Clin. Proc. 77 2002 72 82
22. M. Isihara, I. Inoue, and T. Kawagoe Effect of prodromal angina pectoris on altering the relation between time to reperfusion and outcomes after a first anterior wall acute myocardial infarction Am. J. Cardiol. 91 2003 128 132
23. H.R. Andersen, T.T. Nielsen, and K. Rasmussen A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction N. Engl. J. Med. 349 2003 733 742
24. L Wallentin, P Goldstein, and PW Armstrong Efficacy and safety of tenecteplase in combination with low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting Circulation 108 2003 135 142
25. L.K. Newby, W.R. Rutsch, and R.M. Califf Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators J. Am. Coll. Cardiol. 27 1996 1646 1655
26. M. Marber, and G. Lopaschuk Can we target metabolism and ion flux as a therapy for coronary artery occlusion? Heart Metab. 12 2001 1 2
27. A.C. Guyton Transport of oxygen and carbon dioxide in the blood and body fluids Textbook of medical physiology 8th ed. 1991 WB Saunders Company Philadelphia (Penn) 433 443
28. T.M.S. Chang Oxygen carriers Curr. Opin. Investig. Drugs 3 2002 1187 1190
29. G.S. Hughes Jr., E.J. Antal, and P.K. Locker Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans Crit. Care Med. 24 1996 756 764
30. T. Standl, P. Horn, and S. Wilhelm Bovine haemoglobin is more potent than autologous red blood cells in restoring muscular tissue oxygenation after profound isovolaemic haemodilution in dogs Can. J. Anaesth. 43 1996 714 723
31. J.D. McNeil, D.L. Smith, and D.H. Jenkins Hypotensive resuscitation using a polymerized bovine hemoglobin-based oxygen-carrying solution (HBOC-201) leads to reversal of anaerobic metabolism J. Trauma 50 2001 1063 1075
32. S.K. Lee, D. Morabito, and J.C. Hemphill Small-volume resuscitation with HBOC-201: effects on cardiovascular parameters and brain tissue oxygen tension in an out-of-hospital model of hemorrhage in swine Acad. Emerg. Med. 9 2002 969 976
33. B. Driessen, J.S. Jahr, and F. Lurie Arterial oxygenation and oxygen delivery after hemoglobin-based oxygen carrier infusion in canine hypovolemic shock: a dose-response study Crit. Care Med. 31 2003 1771 1779
34. G.S. Hughes Jr., S.F. Francome, and E.J. Antal Hematologic effects of a novel hemoglobin-based oxygen carrier in normal male and female subjects J. Lab. Clin. Med. 126 1995 444 451
35. C. Boura, A. Caron, and D. Longrois Volume expansion with modified hemoglobin solution, colloids, or crystalloid after hemorrhagic shock in rabbits: effects in skeletal muscle oxygen pressure and use versus arterial blood velocity and resistance Shock 19 2003 176 182
36. A.G. Tsai, and M. Intaglietta The unusual properties of effective blood substitutes Keio J. Med. 51 2002 17 20
37. E.E. Jacobs, M.S. Gawryl, and L.B. Pearce Biopure's room temperature stable hemoglobin-based oxygen carrier. Hemopure (HBOC-201) Interface 10 1999 2 4
38. E.M. Moore Blood substitutes: the future is now J. Am. Coll. Surg. 196 2003 1 17
39. G.S. Hughes, E.P. Yancey, and R. Albrecht Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans Clin. Pharmacol. Ther. 58 1995 434 443
40. D. Erni, R. Wettstein, and S. Schramm Normovolemic hemodilution with Hb vesicle solution attenuates hypoxia in ischemic hamster flap tissue Am. J. Physiol. Heart Circ. Physiol. 284 2003 H1702 H1709
41. 2 affinity Am. J. Physiol. Heart Circ. Physiol. 285 2003 H1140 H1147
42. T. Standl, M. Freitag, and M.A. Burmeister Hemoglobin-based oxygen carrier HBOC-201 provides higher and faster increase in oxygen tension in skeletal muscle of anemic dogs that do stored red blood cells J. Vasc. Surg. 37 2003 859 865
43. E.P. Horn, T. Standl, and S. Wilhelm Bovine hemoglobin increases skeletal muscle oxygenation during 95% artificial arterial stenosis Surgery 121 1997 411 418
44. E.P. Horn, T. Standl, and S. Wilhelm Bovine hemoglobin. HBOC-201 causes a reduction of the oxygen partial pressure in poststenotic skeletal muscle Anaesthesist 47 1998 116 123
45. A. Botzlar, P. Steinhauser, and D. Nolte Effects of ultra-purified polymerized bovine hemoglobin on local tissue oxygen tension in striated skin muscle-an efficacy study in the hamster Eur. Surg. Res. 34 2002 106 113
46. K.E. Loke, P.R. Forfia, and F.A. Recchia Bovine polymerized hemoglobin increases cardiac oxygen consumption and alters myocardial substrate metabolism in conscious dogs: role of nitric oxide J. Cardiovasc. Pharmacol. 35 2000 84 92
47. M.A. Burmeister, C. Rempf, and S. Rehberg Effects of a prophylactic or therapeutic application of cell-free hemoglobin solution HBOC-200 on infarct size after myocardial ischemia and reperfusion in rats Anesthesiology 99 2003 A751
48. M.B. Strange, J.E. Caswell, and S.P. Jones Evaluation of a hemoglobin based blood substitute in a canine model of myocardial ischemia-reperfusion FASEB J. 2000 [Abstract 150, Presented at Experimental Biology 2000, San Diego, California, April 15-18, 2000]
49. T. Standl, E.P. Horn, and M.A. Burmeister Bovine hemoglobin restores myocardial tissue oxygen tension in dogs with acute critical coronary stenosis and extended hemodilution Anesthesiology 91 1999 A697
50. T. Standl Haemoglobin-based erythrocyte transfusion substitutes Expert Opin. Biol. Ther. 1 2001 831 843
51. L.B. Pearce, and M.S. Gawryl Overview of preclinical and clinical efficacy of Biopure's HBOCs T.M.S. Chang Blood substitutes: principles, methods, products and clinical trials 1998 Karger Langer Systems New York (NY) 82 100
52. M. Niquille, M. Touzet, and I. Leblanc Reversal of intraoperative myocardial ischemia with a hemoglobin-based oxygen carrier Anesthesiology 92 2000 882 885